Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 131-140 of 172 for Prostate cancer

Edit search filters
  1. A Study to Evaluate MRI-guided Cryoablation for Focal Native Intermediate Grade Prostate Cancer

    Rochester, MN

  2. Biochemically Recurrent Prostate Cancer Detection With Integration of PSMA PET imaging and Extracellular Vesicle-Based Tumor Monitoring

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study of Bladder Filling Variations During Radiation Therapy in Patients Undergoing Radiation Treatment for Prostate Cancer

  4. A Study to Compare Outcomes of Patients Who Underwent Open and Robotic Prostatectomy for Prostate Cancer

    Rochester, MN

  5. Detecting Significant Prostate Cancer Based on Molecular Alterations Associated With Cancer in Non-neoplastic Prostate Tissue

    Rochester, MN

  6. Study of Molecular Circulatory Biomarkers in Hormone Sensitive and Castration Recurrent Prostate Cancer

    Rochester, MN

  7. A Study to Reduce Disparities in High-Risk Black Men (BM) With Advanced Prostate Cancer Using Patient-Centered Home Care

    Jacksonville, FL

  8. Understanding Financial Toxicity in Management of Advanced Prostate Cancer from Qualitative Approach

    Rochester, MN

  9. SBRT for Oligometastatic Castration-Refractory Prostate Cancer

    Rochester, MN

  10. Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer